- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 28.05. | Pharma leaders meet with PM Takaichi in push for Japan to retain R&D edge | ||
| 28.05. | CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo | ||
| 28.05. | PharmaEssentia taps Incyte alum Eric Vogel as it eyes Besremi expansion | ||
| 28.05. | Kaléo speaks up on allergy awareness to amplify patient stories | ||
| 27.05. | Viridian, awaiting FDA decision, taps WuXi Bio in eye drug supply deal | ||
| 27.05. | ASCO preview: With expectations jacked up, Akeso's ivonescimab to face scrutiny in high-stakes plenary | ||
| 27.05. | As J&J separates from its orthopedics business, it's laying off 56 employees in New Jersey | ||
| 27.05. | Eli Lilly wins argument over Noom's GLP-1 dosing claims | ||
| 27.05. | GLP-1 manufacturer CordenPharma strikes deal for peptide CDMO, lining up new production sites in US and China | ||
| 27.05. | Amid policy and pricing headwinds, US healthcare and life sci faces 'vast field of opportunity': survey | ||
| 27.05. | Biogen investigated by Italian regulator over multiple sclerosis 'market abuse' claims | ||
| 27.05. | FDA delays ruling on AstraZeneca's breast cancer drug after negative adcomm vote | ||
| 26.05. | Radiopharmaceutical outfit Lantheus mulls potential $7B takeover by Curium: Bloomberg | ||
| 26.05. | SK bioscience links up with Colombia to enable local production of varicella vaccine | ||
| 26.05. | After prior FDA manufacturing snub, Gilead's hepatitis D med Hepcludex nabs US nod | ||
| 26.05. | Acadia boosts 'More To Parkinson's' campaign with Ryan Reynolds, Parkinson's voices | ||
| 22.05. | Novartis, AbbVie plan summer layoffs on opposite coasts | ||
| 22.05. | AbbVie, GSK race up patient reputation leaderboard in the UK | ||
| 22.05. | AbbVie plots 85 summer layoffs tied to Allergan unit in California | ||
| 22.05. | Tyra creates awareness day with patient advocates to shine light on a rare cancer | ||
| 22.05. | Europe's CHMP gives thumbs up to AstraZeneca's breast cancer drug after thumbs down from FDA adcomm | ||
| 22.05. | AstraZeneca, Daiichi beat Gilead to first-line TNBC with FDA nod for Datroway | ||
| 22.05. | Fierce Pharma Asia-Merck-Kelun ADC's triple wins; Tools in China licensing deals; Takeda's $885M antitrust loss | ||
| 21.05. | ASCO: Merck, Kelun's sac-TMT ADC combo beats Keytruda by 65% on progression in first-line lung cancer | ||
| 21.05. | Lilly accuses church-linked pharmacies, wholesalers and more of running $200M+ rebate fraud scheme |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.